The Y192 site in Lck’s SH2 domain is dynamically phosphorylated in response to TCR engagement, functioning as part of a negative feedback loop. Phosphorylation at Y192 prevents the phosphatase CD45 from dephosphorylating Lck’s inhibitory C-terminal tail (Y505), thereby stabilizing Lck in its inactive conformation . This regulation ensures precise control over TCR signaling thresholds, balancing activation and tolerance. The Phospho-LCK (Y192) Antibody enables direct visualization and quantification of this phosphorylation event in cells or tissues.
Jurkat T Cells: Studies using Jurkat T cells reconstituted with Lck Y192E (phospho-mimetic) or Y192A (non-phosphorylatable) mutants revealed that Y192 phosphorylation correlates with attenuated calcium flux and Zap70 activation. Y192E/A variants exhibited delayed and reduced signaling compared to wild-type Lck .
Primary T Cells: Knock-in mice harboring Y192E mutations showed hyperphosphorylation of Y505, impaired thymocyte development, and defective TCR-mediated proliferation .
Thymic analysis of Lck Y192E mice demonstrated a developmental block at the β-selection checkpoint, with reduced numbers of double-negative (DN) thymocytes and impaired Erk1/2 activation . This defect mirrored CD45 deficiency, underscoring Y192’s role in regulating Lck activity during thymopoiesis .
In vitro kinase assays revealed that Lck Y192E retains enzymatic activity comparable to wild-type Lck, suggesting that Y192 primarily regulates Lck localization and substrate access rather than intrinsic catalytic function .
The Phospho-LCK (Y192) Antibody is employed in:
Western Blotting: To monitor Y192 phosphorylation in response to TCR stimulation or kinase inhibitors (e.g., PP2).
Immunoprecipitation: To isolate phosphorylated Lck for downstream analysis of interacting proteins (e.g., CD45, Zap70).
Flow Cytometry: To assess Y192 phosphorylation in primary T cells or thymocytes during development.
Immunohistochemistry: To localize phosphorylated Lck in tissues, aiding studies of immune regulation or lymphoid malignancies .
Phospho-LCK (Y192) Antibody is critical for studying immune dysregulation. Aberrant Y192 phosphorylation has been implicated in:
Immunodeficiency: Defects in Y192 regulation may impair T-cell activation, increasing susceptibility to infections .
Leukemia: Lck hyperactivation due to Y192 mutations could contribute to oncogenic signaling in T-cell malignancies .
Immunotherapy: Understanding Y192 dynamics may inform strategies to enhance anti-tumor T-cell responses .
LCK (Lymphocyte-specific protein tyrosine kinase) is a Src Family Kinase (SFK) that sets a critical threshold for T cell activation by phosphorylating the TCR complex and the Zap70 kinase. Y192 is a tyrosine residue located within the SH2 domain of LCK that serves as an underappreciated regulatory phosphosite conserved amongst all human SFKs . Phosphorylation at Y192 profoundly affects the amount of active LCK in cells, thereby influencing TCR sensitivity .
Research has demonstrated that modification of Y192 inhibits the ability of CD45 to associate with LCK in cells and dephosphorylate the C-terminal tail, preventing LCK from adopting an active open conformation . This represents a negative feedback mechanism that responds to signaling events to tune active LCK amounts and TCR sensitivity, making it crucial for proper T cell function and development .
The conventional view of SFK regulation has focused on two tyrosine phosphorylation sites: Y394 (activation loop) and Y505 (C-terminal tail) . Y394 phosphorylation promotes the active conformation of LCK, with studies showing that the free LCK pool exhibits more activating Y394 phosphorylation than coreceptor-bound LCK . Conversely, Y505 phosphorylation promotes the closed, inactive conformation through intramolecular binding to LCK's own SH2 domain.
Y192 phosphorylation represents a third critical regulatory mechanism that functions differently than the other two sites . Unlike direct conformational control, Y192 phosphorylation alters the binding specificity of the SH2 domain and inhibits the association of LCK with phosphatases like CD45 . This leads to hyperphosphorylation of the inhibitory C-terminal tail (Y505), indirectly maintaining LCK in an inactive state through a sophisticated regulatory circuit .
Several kinases have been implicated in Y192 phosphorylation, suggesting a complex regulatory network:
Zap70: Selective inhibition of Zap70 leads to a pronounced decrease in Y192 phosphorylation in both resting and activated T cells, along with increased phosphorylation of the LCK-activating tyrosine 394 (Y394) .
ITK: This Tec family tyrosine kinase located downstream of Zap70 has been implicated in Y192 phosphorylation . ITK, along with Syk and Zap70, has previously been identified as potentially responsible for this modification .
Zap70-mediated pathways: Since Zap70 is an LCK substrate, this relationship suggests a negative feedback loop wherein LCK activates Zap70, which then directly or indirectly leads to phosphorylation of LCK at Y192, thereby dampening LCK activity .
This multi-kinase involvement highlights the sophisticated nature of LCK regulation and the central role of Y192 in feedback control mechanisms within T cell signaling.
For reliable detection and quantification of LCK Y192 phosphorylation, researchers should consider these validated approaches:
Western blotting with specific antibodies represents the most common method, where Lck phosphorylation status can be reported by the intensity ratio of pY394-Lck (active Lck)/Y394-nonphospho-Lck (inactive Lck) . When using this approach, it's crucial to supplement lysis buffer with SFK inhibitor PP2 (20 μM) together with a protease-phosphatase inhibitor mixture during cell lysis and immunoprecipitation to maintain Lck phosphorylation status .
For quantification, the LI-COR fluorescent imaging system enables accurate measurement of intensity ratios between different phosphorylated forms on the same immunoblots . This approach has been successfully validated by showing that treatment with pervanadate (phosphatase inhibitor) increases the pY394/Y394-nonphospho ratio, while PP2 (SFK inhibitor) decreases it .
Alternative approaches include FRET-based biosensors such as ZapLck, which can visualize Lck kinase activity with high spatiotemporal resolution in live cells . While not directly measuring Y192 phosphorylation, these biosensors can detect functional consequences of Y192 phosphorylation status in real-time.
When validating a Phospho-LCK (Y192) antibody, implement these critical controls:
Y192F mutation comparison: The most definitive validation involves comparing antibody reactivity between wild-type LCK and LCK with a Y192F mutation . The Y192F mutant cannot be phosphorylated at position 192 and should show no reactivity with a phospho-specific antibody.
Phosphatase treatment: Treat cell lysates with phosphatases to remove phosphorylation and confirm the loss of antibody reactivity. Conversely, treatment with pervanadate (phosphatase inhibitor) should increase the signal if the antibody is phospho-specific .
Kinase inhibitor treatments: Treatment with Zap70 inhibitors should decrease Y192 phosphorylation if the antibody is specific, as Zap70 inhibition leads to a pronounced decrease in Y192 phosphorylation .
Stimulus-dependent changes: Verify that antibody reactivity changes appropriately with TCR stimulation, consistent with the known biology of Y192 phosphorylation .
Multiple validation approaches should be used in conjunction to ensure antibody specificity before proceeding with experimental studies.
To comprehensively assess the functional consequences of Y192 phosphorylation, include these essential controls:
Y192F mutant: This mutant prevents phosphorylation at position 192 and serves as a crucial negative control . Studies have shown that Y192F mutation blocks critical TCR proximal signaling events and impairs thymocyte development in retrogenic mice .
Y505F mutant: This constitutively active form of LCK provides a comparison point for distinguishing between different regulatory mechanisms . Researchers have demonstrated that Y192F-induced clustering is fundamentally different from Y505F-induced clustering, with Y192F clusters being more numerous but having very low density compared to the fewer but denser Y505F clusters .
Comparison with other phosphorylation sites: Always monitor Y394 and Y505 phosphorylation alongside Y192 to understand the interrelationship between different regulatory mechanisms . This is particularly important as these sites form part of an integrated regulatory system.
Signaling downstream: Measure functional outcomes such as TCR phosphorylation, calcium flux, and cytokine production to connect Y192 phosphorylation status with T cell function .
These controls enable researchers to distinguish the specific effects of Y192 phosphorylation from other regulatory mechanisms affecting LCK activity.
Y192 phosphorylation significantly impacts LCK's spatial organization in the plasma membrane of T cells through distinct mechanisms:
The molecular basis for this difference appears to involve protein-protein interactions mediated by the SH2 domain rather than conformational changes . Y192 phosphorylation modifies the binding specificity of the LCK SH2 domain, affecting its interaction with various signaling partners.
Scientists have proposed that the "declustering" of LCK when Y192 is phosphorylated may represent a mechanism for downregulating LCK signaling, similar to what has been described for Zap70 clusters . Alternatively, it could function as a way of "recycling" the LCK population engaged in clusters, either to allow LCK molecules to search for more triggered TCRs or to engage in other processes related to later T cell signaling events .
Y192 phosphorylation significantly alters LCK's interaction landscape, functioning as a molecular switch that regulates the binding specificity of the SH2 domain:
These altered interactions collectively contribute to a sophisticated regulatory mechanism that helps fine-tune T cell signaling responses through control of active LCK levels.
Y192 phosphorylation functions within a sophisticated negative feedback loop that modulates TCR signaling thresholds:
The mechanism begins with TCR stimulation activating LCK, which phosphorylates ITAMs on the TCR complex and Zap70 . Activated Zap70 (directly or via ITK) then phosphorylates LCK at Y192 . This phosphorylation inhibits CD45 association with LCK, preventing dephosphorylation of the inhibitory Y505 site . Consequently, Y505 remains phosphorylated, promoting the closed, inactive LCK conformation and reducing the pool of active LCK .
This feedback circuit is physiologically significant - mutation of Y192 (Y192F) blocks critical TCR proximal signaling events and impairs thymocyte development in retrogenic mice . The Y192F defects are caused by hyperphosphorylation of the activating Y394 site, consistent with disruption of the negative feedback loop .
Studies using FRET biosensors have shown that up to 62% of LCK may be preactivated in Jurkat cells, with LckY394F almost completely abolishing this preactivation . This suggests that Y394 phosphorylation, regulated in part through Y192 phosphorylation, is critical for maintaining appropriate levels of active LCK in resting and stimulated T cells .
Zap70 and LCK form a bidirectional regulatory circuit involving Y192 phosphorylation:
Selective inhibition of Zap70 leads to a pronounced decrease in Y192 phosphorylation in both resting and activated T cells . This coincides with increased phosphorylation of the LCK-activating tyrosine 394 (Y394), consistent with a model where Y192 phosphorylation negatively regulates LCK activity .
The molecular mechanism involves several interdependent steps: LCK phosphorylates the ITAM domains of the TCR complex, creating docking sites for Zap70 . LCK then further phosphorylates Zap70 at residues Y315 and Y319, inducing Zap70 activation . LCK subsequently binds to phosphorylated Y319 on Zap70, an event that stabilizes the activated conformation of LCK and facilitates further Zap70 activation .
Once activated, Zap70 phosphorylates the adaptor protein LAT, which contributes to LCK phosphorylation at Y394 upon TCR stimulation . LAT also interacts with LCK upon TCR activation and preferentially associates with the open form of LCK .
This reciprocal relationship creates a regulatory circuit where LCK activates Zap70, which then feeds back to regulate LCK activity through Y192 phosphorylation, helping to fine-tune T cell receptor sensitivity.
The Y192F mutation, which prevents phosphorylation at this regulatory site, has profound effects on T cell function and development:
Studies in retrogenic mice have demonstrated that the Y192F mutation impairs thymocyte development, establishing the physiological importance of Y192 phosphorylation in vivo . At the molecular level, Y192F mutation blocks critical TCR proximal signaling events by disrupting the negative feedback loop that regulates LCK activity .
The mutation causes hyperphosphorylation of the activating Y394 site and increases TCR phosphorylation, suggesting enhanced LCK activity . This is consistent with the model where Y192 phosphorylation normally serves to dampen LCK activity as part of a negative feedback mechanism .
Research also shows that Y192F mutation significantly alters LCK clustering patterns, with Y192F mutants forming more numerous but less dense clusters compared to both wild-type LCK and constitutively active Y505F LCK . These clustering differences likely contribute to the altered signaling properties of Y192F LCK.
The developmental defects observed with Y192F mutation highlight how precise regulation of LCK activity through Y192 phosphorylation is essential for establishing appropriate signaling thresholds during T cell development, where TCR signal strength determines positive and negative selection outcomes.
When investigating LCK Y192 phosphorylation, researchers should be aware of several critical technical considerations:
Preserving phosphorylation status: LCK can transautophosphorylate its Y394 site even after cell lysis, potentially confounding results . To maintain LCK phosphorylation status accurately, supplement lysis buffer with SFK inhibitor PP2 (20 μM) together with a protease-phosphatase inhibitor mixture during cell lysis and immunoprecipitation incubation .
Antibody validation: Use multiple approaches to validate phospho-specific antibodies, including Y192F mutants as negative controls, and treatments with phosphatase inhibitors (pervanadate) or SFK inhibitors (PP2) as positive and negative controls respectively .
Quantification methods: For accurate quantification, calculate the intensity ratio of phosphorylated versus non-phosphorylated forms using systems like the LI-COR fluorescent imaging system . This approach has been validated by showing appropriate ratio changes with phosphatase or kinase inhibitors .
Cell system selection: Different experimental systems have distinct advantages - JCam cell lines reconstituted with wild-type or mutant LCK provide a clean background for molecular studies , while primary T cells and in vivo models are essential for confirming physiological relevance .
Dynamic measurements: Given the dynamic nature of Y192 phosphorylation, consider time-course experiments and live-cell imaging approaches like FRET biosensors to capture temporal regulation .
These technical considerations ensure reliable and reproducible results when studying this critical regulatory mechanism in T cell signaling.
To comprehensively assess the functional significance of Y192 phosphorylation in T cell biology, implement these experimental approaches:
Comparative mutational analysis: Express wild-type LCK alongside Y192F (preventing phosphorylation) and Y192E (potential phosphomimetic) mutants in LCK-deficient cells like JCam1.6 . Compare these with other regulatory mutants like Y505F (constitutively active) to distinguish between different regulatory mechanisms .
Signaling cascade analysis: Measure proximal TCR signaling events (ITAM phosphorylation, Zap70 activation) and downstream outcomes (calcium flux, NFAT activation, cytokine production) to establish the consequences of Y192 phosphorylation across the signaling pathway .
Protein interaction studies: Use techniques like co-immunoprecipitation, proximity ligation assays, or FRET-based approaches to investigate how Y192 phosphorylation affects LCK's interactions with key partners like CD45, TSAd, and SHP-1 .
Advanced imaging approaches: Employ super-resolution microscopy techniques like PALM to visualize how Y192 phosphorylation affects LCK clustering and spatial organization in the plasma membrane . Complement with FRET biosensors to monitor LCK activity in real-time .
In vivo models: Use retrogenic mice expressing wild-type or Y192F LCK to assess developmental consequences and immune function in a physiological context .
This multi-faceted approach will provide comprehensive insights into how Y192 phosphorylation regulates LCK function across different biological contexts.